Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436)

Bruno Bastos

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436)

Bruno Bastos

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Jan 1 2024
Event	Journal of Clinical Oncology - Duration: Jan 1 2024 → …

Conference

Conference	Journal of Clinical Oncology
Period	1/1/24 → …

Cite this

@conference{84e511d4a72c414eb2c98acb6e562842,

title = "Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436)",

author = "Bruno Bastos",

year = "2024",

month = jan,

day = "1",

language = "American English",

note = "Journal of Clinical Oncology ; Conference date: 01-01-2024",

}

TY - CONF

T1 - Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436)

AU - Bastos, Bruno

PY - 2024/1/1

Y1 - 2024/1/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/5077

M3 - Presentation

T2 - Journal of Clinical Oncology

Y2 - 1 January 2024

ER -

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436)

Conference

Other files and links

Cite this